|
[1]Hagiya M, Francarilla A, Polimeno L, et a1.Cloning and sequenceanalysis of the augment of live regenerating (ALR) gone:Expressionof biologically active recombination ALR and demonstration of tissuedistribution[J].Proc Natl A-cad Sci USA, 1994, 91∶8142-8146.
|
|
[2]林莹, 孔祥平, 梁世中.肝再生增强因子生物功能和作用机理研究进展[J].中国生化药物杂志, 2006, 27 (2) ∶122-124.
|
|
[3]孔祥平, 易学瑞.肝再生增强因子研究进展[J].传染病信息.2008, 21 (2) ∶80-84.
|
|
[4]Zhao YL, Tang F, Cheng JW, et a1.An initiator and its flanking el-ements function as a core promoter driving transcription of the Hepa-topoietin gene[J].FEBS Letters, 2003, 540 (1-3) ∶58-64.
|
|
[5]Gatzidou E, Kouraklis G, Theocharis S.Insights on augmenter ofliver regeneration cloning and function[J].World J Gastroenterol, 2006, 12 (31) ∶495l-4958.
|
|
[6]潘艳, 鞠桂芝, 佟明华, 等.人肝再生增强因子FAD辅助的巯基氧化酶活性测定及其活性位点研究[J].中国病理生理杂志, 2006, 22 (11) ∶2247-2250.
|
|
[7]Wang CP, Zhou L, Su SH, et a1.Augmenter of liver regenerationpromotes hepatocyte proliferation induced by Kupffer cells[J].World J Gastroenterol, 2006, 12 (30) ∶4859-4865.
|
|
[8]Francavilla A, Hagiya M, Porter KA, et al.Augmenter of liver re-generation:its place in the universe of hepatic growth factors[J].Hepatology, 1994, 20 (3) ∶747-757.
|
|
[9]Pawlowski R, Jura J.ALR and liver regeneration[J].Mol Cell Bio-chem, 2006, 288 (1-2) ∶159-169.
|
|
[10]龙飞伍, 梁绍勇, 龚建平.肝再生增强因子及其基因家族的研究进展[J].生理科学进展, 2007, 38 (4) ∶361-364.
|
|
[11]石小枫, 孙航, 唐琳, 等.肝再生增强因子对外原性抗原引起机体免疫应答影响的研究[J].免疫学杂志, 2007, 23 (6) ∶606-609.
|
|
[12]张勇, 宋良文, 尹纪业, 等.肝再生增强因子促进肝再生的细胞信号途径研究[J].中华肝胆外科杂志, 2007, 13 (5) ∶328-331.
|
|
[13]佟明华, 陈思强, 姚汝华, 等.用酵母双杂交系统筛选人肝再生增强因子的相互作用蛋白[J].中华肝脏病杂志, 2003, 24 (4) ∶734-736.
|
|
[14]佟明华, 孔祥平, 李脉, 等.人肝再生增强因子在体外可与Na+-K+-ATPase特异性结合[J].中国病理生理杂志, 2006, 19 (3) ∶310-313.
|
|
[15]Pierre SV, Xie Z.The Na+-K+-ATPase receptor complex:itsorganization and membership[J].Cell Biochem Biophys, 2006, 46 (3) ∶303-316.
|
|
[16]Thasler WE, Dayoub R, Muhlbauer M, et a1.Repression of cyto-chrome P450 activity in human hepatocytes in vitro by a novel hepa-totrophic factor, augmenter of liver regener-ation[J].J PharmacolExp Ther, 2006, 316 (2) ∶822-829.
|
|
[17]Lisowsky T, Lee JE, Polimeno L, et al.Mammalian augmenter ofliver regeneration protein is a sulfhydryl oxidase[J].Dig Liver Dis, 2001, 33 (2) ∶173-180.
|
|
[18]Wang Y, Lu C, Wei H, et a1.Hepatopoietin interacts directly withCOP9 signalosome and regulates AP-1 activity[J].FEBS Lett, 2004, 572 (1) ∶85-91.
|
|
[19]Polimeno L, Capuano F, Marangi LC, et a1.The augmenter of liverregeneration induces mitochondrial gene expression in rat liver andenhances oxidative phosphorylation capacity of livermitochondria[J].Dig Liver Dis, 2000, 32 (6) ∶510-517.
|
|
[20]Farrell SR, Thorpe C.Augmenter of liver regeneration:a flavin-dependent sulthydryl oxidase with cytochrome Creductaseactivity[J].Biochemistry, 2005, 44 (5) ∶1532-1541.
|
|
[21]Lu C, Li Y, Zhao Y, et a1.Intracrine hepatopoietin potentiates AP-1 activity through JAB1 independent of MAPK pathway[J].FASEB-J, 2002, 16 (1) ∶90-92.
|
|
[22]Wang G, Yang X, Yong L, et a1.Identification and characteriza-tion of receptor for mammalian hepatopoeitin that is homologous toyeast ERV1[J].J Biol Chem, 1999, 274 (17) ∶11469-11472.
|
|
[23]Abe J, Baines CP, Berk BC.Role of mitogen-activated proteinkinases in ischemia and reperfusion injury:the good and thebad[J].Circ Res, 2000, 86 (61) ∶607-609.
|
|
[24]Chen XX, Li Y, Wei HD, et a1.The potentiation role of hepatopoi-etin on activator protein-1 is dependent on its shlflaydryl oxidaseactivity[J].Jonmal of Biological Chemistry, 2003, 278 (49) ∶49022-49030.
|
DownLoad: